Holdings
venBio Partners LLC
As of Sep 30, 2026, venBio Partners LLC reported 7 positions worth US$342M. Largest: Parabilis Medicines, Inc., Attovia Therapeutics, Inc. and Achieve Life Sciences, Inc. What it bought and sold, with each filing.
| Company | Shares | Value as reported | Change | As of |
|---|---|---|---|---|
| Parabilis Medicines, Inc. | 5.27M | US$170M | no change | Sep 30, 2026 |
| Attovia Therapeutics, Inc. | 4.18M | US$71.7M | new | Sep 30, 2026 |
| Achieve Life Sciences, Inc. | 5.91M | US$47.9M | no change | Sep 30, 2026 |
| Alumis Inc. | 4.19M | US$31M | −337K | Sep 30, 2026 |
| ALX Oncology Holdings Inc. | 12.9M | US$17.9M | no change | Sep 30, 2026 |
| Lyell Immunopharma, Inc. | 338K | US$3.31M | no change | Sep 30, 2026 |
| Lisata Therapeutics, Inc. | 156K | US$225K | new | Sep 30, 2026 |